FAIR LAWN, N.J.--(BUSINESS WIRE)--Marking an advance in the widespread distribution of rapid pain relief from procedures involving venipuncture, intravenous cannulation and laser ablation of superficial skin lesions, Vyteris, Inc. (OTCBB: VYHN) announced the commercial availability of LidoSite® to the 40 million American patients in physician offices who are needle averse or even phobic.
